SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001679363-23-000075
Filing Date
2023-11-03
Accepted
2023-11-03 07:15:55
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q morf-20230930.htm   iXBRL 10-Q 1431629
2 EX-31.1 morf-2023930x10qex311.htm EX-31.1 10266
3 EX-31.2 morf-2023930x10qex312.htm EX-31.2 10303
4 EX-32.1 morf-2023930x10qex321.htm EX-32.1 4637
5 EX-32.2 morf-2023930x10qex322.htm EX-32.2 4717
  Complete submission text file 0001679363-23-000075.txt   5387270

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT morf-20230930.xsd EX-101.SCH 28439
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT morf-20230930_cal.xml EX-101.CAL 48517
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT morf-20230930_def.xml EX-101.DEF 172189
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT morf-20230930_lab.xml EX-101.LAB 403512
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT morf-20230930_pre.xml EX-101.PRE 277659
54 EXTRACTED XBRL INSTANCE DOCUMENT morf-20230930_htm.xml XML 656401
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 (781) 996-0955
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38940 | Film No.: 231374482
SIC: 2834 Pharmaceutical Preparations